Alpha: an early version. Promise cards are checked by two editors and by AI Journalist, our automated reviewer. Become an editor

LedgerGov.UK
← All promises
HM GovernmentHealth

Halve early clinical trial assessment to 14 days

“Cut by half the initial assessment target for qualifying Phase 1 clinical trials to 14 days.”

PromisedPress release (Medicines and Healthcare products Regulatory Agency), 14 Oct 2026
  1. Promised

Where it stands

One of the commitments in the 2030 Strategy of the Medicines and Healthcare products Regulatory Agency (MHRA), an executive agency of the Department of Health and Social Care, set out on 14 October 2026. The release does not say which Phase 1 trials qualify, gives no date for the new target and does not tie it to 2030. The card moves when the MHRA starts reporting against the 14-day target.

What has happened

  1. Oct 2026The MHRA's 2030 Strategy commits to halving the initial assessment target for qualifying Phase 1 clinical trials to 14 days, Promised

About the cost

No cost has been published.

More detail

Sources (1)
How cards are checked

Status follows the promise standard, the same for every party. A status changes only on evidence. Anyone named on a card can reply, and replies are published next to it. AI Journalist is our automated reviewer: it re-reads every card against its live sources (the quote word for word, dates, evidence, status, cost, neutral wording, legal risk). Two editors also check every card against its sources and approve it.

Related promises

Every promise in Health